UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
A number of late stage failures from British biotech firms have left a looming question mark over the future of …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

